Virios Therapeutics to Present at the H.C. Wainwright Virtual BioConnect ConferenceBusiness Wire • 01/04/21
Virios Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Over-Allotment OptionBusiness Wire • 12/21/20